A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the J&J-Janssen Covid-19 vaccine.

MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.

Research projects will harness the power of artificial intelligence to positively impact human health.

A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.

Deep-learning model has been used successfully on patients, may lead to more consistent screening procedures.